Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

FDA advisory committee recommends Integrilin approval

Jan. 29, 1998

Clinical development of LM-AS-013 advances at Green Cross

Jan. 29, 1998

Additional data submitted to FDA to support Novastan NDA

Jan. 26, 1998

Ortho reveals new fibrinogen receptor antagonists

Jan. 26, 1998

Lilly prepares compounds for controlling TxA2

Jan. 23, 1998

Boehringer Ingelheim develops new antiplatelet agents

Jan. 21, 1998

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

DuPont Merck develops new factor Xa inhibitors as anticoagulants

Jan. 16, 1998

Oral heparin preparation completes additional phase I trials

Jan. 16, 1998

Merck & Co. describes new thrombin inhibitors

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...